GLP1R and Parkinson disease: The DPP4i mechanisms of action are unclear regarding PD, since DPP4i cannot cross the BBB; it has been hypothesized that DPP4i could alleviate PD symptoms by increasing the blood levels of GLP-1 and GLP-2 [128].